Deborah Morosini - Net Worth and Insider Trading
Deborah Morosini Net Worth
The estimated net worth of Deborah Morosini is at least $1,141 dollars as of 2024-09-20. Deborah Morosini is the EVP, Chief of Clinical Affairs of Prelude Therapeutics Inc and owns about 444 shares of Prelude Therapeutics Inc (PRLD) stock worth over $1,141. Details can be seen in Deborah Morosini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deborah Morosini has not made any transactions after 2021-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deborah Morosini
Deborah Morosini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deborah Morosini owns 1 companies in total, including Prelude Therapeutics Inc (PRLD) .
Click here to see the complete history of Deborah Morosini’s form 4 insider trades.
Insider Ownership Summary of Deborah Morosini
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2021-12-15 | EVP & Chief of Clinical Affairs |
Deborah Morosini Latest Holdings Summary
Deborah Morosini currently owns a total of 1 stock. Deborah Morosini owns 444 shares of Prelude Therapeutics Inc (PRLD) as of December 15, 2021, with a value of $1,141.
Latest Holdings of Deborah Morosini
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2021-12-15 | 444 | 2.57 | 1,141 |
Holding Weightings of Deborah Morosini
Deborah Morosini Form 4 Trading Tracker
According to the SEC Form 4 filings, Deborah Morosini has made a total of 6 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Prelude Therapeutics Inc is the sale of 28,751 shares on December 15, 2021, which brought Deborah Morosini around $373,763.
Insider Trading History of Deborah Morosini
- 1
Deborah Morosini Trading Performance
GuruFocus tracks the stock performance after each of Deborah Morosini's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deborah Morosini is 191.75%. GuruFocus also compares Deborah Morosini's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deborah Morosini within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deborah Morosini's insider trading performs compared to the benchmark.
Performance of Deborah Morosini
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.6 | | | | | |
| Relative Return to S&P 500(%) | 21.36 | | | | | |
Deborah Morosini Ownership Network
Deborah Morosini Owned Company Details
What does Prelude Therapeutics Inc do?
Who are the key executives at Prelude Therapeutics Inc?
Deborah Morosini is the EVP & Chief of Clinical Affairs of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include director & President & CEO Krishna Vaddi , Chief Legal Counsel & Corp Sec. Bryant David Lim , and Chief Financial Officer Laurent Chardonnet .
Prelude Therapeutics Inc (PRLD) Insider Trades Summary
Over the past 18 months, Deborah Morosini made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 13,756 shares made by Krishna Vaddi , a net purchase of 869,565 shares made by David P Bonita , and a net purchase of 869,565 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,280 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,760,286 shares were bought by its insiders, resulting in a net purchase of 1,747,006 shares.
Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prelude Therapeutics Inc Insider Transactions
Deborah Morosini Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah Morosini. You might contact Deborah Morosini via mailing address: C/o Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington De 19803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
